Investing
By Ben Glickman Shares of Verve Therapeutics surged Tuesday after revenue jumped in the third quarter. The stock was up 29% to $19.31 in...
Hi, what are you looking for?
IntelTEXTA
IntelTEXTA
Investing
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s highlights of the most timely ETF news emailed to you weekly....
Investing
In these times of deep divisions, one thing Americans can agree on is the Super Bowl. It has become our secular version of Carnival...
Investing
A glimmer of hope appeared Friday for beleaguered New York Community Bancorp after its stock rose 17% on strong trading volume. Investors seemed reassured...
Investing
Key News Asian equities were mixed overnight on light news. Hong Kong and Mainland China eased off morning gains in the afternoon. Real estate...
Investing
By Will Feuer Kyndryl Holdings narrowed its fiscal second-quarter loss as the provider of information-technology-infrastructure services cut costs ahead of schedule. The company, which...
Investing
When describing the municipal bond market, the first adjectives are usually “staid” or “stodgy”. The terms “data-driven” or “technologically cutting edge” are not usually...
Investing
By Will Feuer Kyndryl Holdings raised its cost-savings targets for the current fiscal year, citing progress using automation to streamline operations and the removal...
Investing
2024 is setting up to be a great year for us contrarian dividend investors—but to take full advantage, we need to buy now—while fear...
Investing
By Denny Jacob Gilead Sciences raised its outlook for 2023. The biopharmaceutical company forecast total sales between $26.7 billion and $26.9 billion versus its...
Investing
It took a while, but utility stocks are finally starting to pop. They still look appealing even after a recent gain. The Utilities Select...
Investing
Much is made of Warren Buffett’s conversion from his early days as a deep-value investor along the lines of his mentor Benjamin Graham to...
Investing
Citigroup has a steep hill to climb—something it knows all too well. Expenses are too high, the staff is bloated, profit margins are too...
